Erythrocin Stearate is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Pd-rx Pharmaceuticals, Inc.. The primary component is Erythromycin Stearate.
Product ID | 55289-112_851a2f10-f4d6-e11f-e053-2991aa0aafbf |
NDC | 55289-112 |
Product Type | Human Prescription Drug |
Proprietary Name | Erythrocin Stearate |
Generic Name | Erythromycin Stearate |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2011-08-01 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA060359 |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Substance Name | ERYTHROMYCIN STEARATE |
Active Ingredient Strength | 250 mg/1 |
Pharm Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2011-10-03 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA060359 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-10-03 |
Marketing Category | ANDA |
Application Number | ANDA060359 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-10-03 |
Marketing Category | ANDA |
Application Number | ANDA060359 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-10-03 |
Marketing Category | ANDA |
Application Number | ANDA060359 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-10-03 |
Marketing Category | ANDA |
Application Number | ANDA060359 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-10-03 |
Marketing Category | ANDA |
Application Number | ANDA060359 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-10-03 |
Marketing Category | ANDA |
Application Number | ANDA060359 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-10-03 |
Marketing Category | ANDA |
Application Number | ANDA060359 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-10-03 |
Marketing Category | ANDA |
Application Number | ANDA060359 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-10-03 |
Ingredient | Strength |
---|---|
ERYTHROMYCIN STEARATE | 250 mg/1 |
SPL SET ID: | 26f2704c-92ae-41c5-badc-dbebfb2eed35 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
10544-594 | Erythrocin Stearate | Erythromycin Stearate |
10544-595 | Erythrocin Stearate | Erythromycin Stearate |
24338-106 | Erythrocin Stearate | ERYTHROMYCIN STEARATE |
50090-0025 | Erythrocin Stearate | ERYTHROMYCIN STEARATE |
55289-112 | Erythrocin Stearate | ERYTHROMYCIN STEARATE |